Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, May, 2009, PR & Med Ed

New pharmaceutical account wins notified to us by the winning agency for the period March 2009 and April 2009 inclusive:

New pharmaceutical account wins notified to us by the winning agency for the period March 2009 and April 2009 inclusive:

 

CLIENT

PRODUCT

THERAPEUTIC AREA

WINNING AGENCY

AlmirallSolarazeDermatologySignature Healthcare Communications
CelgeneVidazaHaematologySuccinct Healthcare Communications
EMD Serono
n/a
InfertilityMedaxial
GaldermaNew productDermatologySignature Healthcare Communications
GenzymeMozobilOncologyMedaxial
GenzymeThyrogenendocrinology / oncology
Medaxial
Lifeblood: The Thrombosis Charity
National Thrombosis Awareness Week
CorporateAthena
Mundipharma
Strategic planning processes and European Internal Comms engagement
Corporate
JYC Global
Napp Pharmaceuticals
OxycontinPalliative Care
Signature Healthcare Communications
Novartis global
Exelon patch
Neuroscience
Just::
Novartis global*
Stalevo
Neuroscience
Just::
Novartis
NHS engagement
Diabetes, Hypertension, CV
JYC Global
Novartis Oncology International
Zometa
Oncology
PraeMedica
Orchid
Male cancer awareness week
Corporate
Spink
Schering Plough
NHS project work
Cardiovascular
JYC Global
SKCINCorporateSkin cancer
Signature Healthcare Communications

*Clarification: it was not made clear in the April issue of PM that Just:: was hired by Novartis to work on global communications and that in the UK Stalevo is still marketed by Orion Pharma UK.

Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

8th June 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics